How an Early Network Meta-Analysis Can Inform Clinical Trial Design and Help with Health Technology Assessment Submissions
Abstract
In this article, Yingxin Xu et al. show several examples illustrating the value that performing an early NMA brings to phase III trial planning
Authors
Yingxin Xu Kyle Fahrbach Grace Jennings Floortje van Nooten